{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825893835679616.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1053/j.gastro.2008.05.031"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0016508508008500?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0016508508008500?httpAccept=text/plain"}}],"dc:title":[{"@value":"Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825893835679623","@type":"Researcher","foaf:name":[{"@value":"Erik H.C.J. Buster"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893835679627","@type":"Researcher","foaf:name":[{"@value":"Hajo J. Flink"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893835679746","@type":"Researcher","foaf:name":[{"@value":"Yilmaz Cakaloglu"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893835679744","@type":"Researcher","foaf:name":[{"@value":"Krzysztof Simon"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893835679617","@type":"Researcher","foaf:name":[{"@value":"Jörg Trojan"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893835679624","@type":"Researcher","foaf:name":[{"@value":"Fehmi Tabak"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893835679619","@type":"Researcher","foaf:name":[{"@value":"Thomas M.K. So"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893835679618","@type":"Researcher","foaf:name":[{"@value":"S. Victor Feinman"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893835679625","@type":"Researcher","foaf:name":[{"@value":"Tomasz Mach"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893835679745","@type":"Researcher","foaf:name":[{"@value":"Ulus S. Akarca"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893835679622","@type":"Researcher","foaf:name":[{"@value":"Martin Schutten"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893835679620","@type":"Researcher","foaf:name":[{"@value":"Wanda Tielemans"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893835679616","@type":"Researcher","foaf:name":[{"@value":"Anneke J. van Vuuren"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893835679626","@type":"Researcher","foaf:name":[{"@value":"Bettina E. Hansen"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893835679621","@type":"Researcher","foaf:name":[{"@value":"Harry L.A. Janssen"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00165085"}],"prism:publicationName":[{"@value":"Gastroenterology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2008-08","prism:volume":"135","prism:number":"2","prism:startingPage":"459","prism:endingPage":"467"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0016508508008500?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0016508508008500?httpAccept=text/plain"}],"createdAt":"2008-05-16","modifiedAt":"2025-09-16","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004235757163264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709456608384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Long-Term Outcome of Sequential Therapy with Lamivudine Followed by Interferon-β in Nucleoside-Naive, Hepatitis B e-Antigen-Positive Patients with Chronic Hepatitis B Virus Genotype C Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285714664842368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Factors associated with the decrease in hepatitis B surface antigen titers following interferon therapy in patients with chronic hepatitis B: Is interferon and adefovir combination therapy effective?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168116348928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JSH Guidelines for the Management of Hepatitis B Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181214486272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340539480704","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848655057424128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"4′‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657213536896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204792984064","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"日本肝臓学会コンセンサス神戸2009：C型肝炎の診断と治療"},{"@language":"en","@value":"JSH Consensus Kobe 2009: Diagnosis and Treatment of Hepatitis C"},{"@language":"ja-Kana","@value":"ニホン カンゾウ ガッカイ コンセンサス コウベ 2009 Cガタ カンエン ノ シンダン ト チリョウ"},{"@value":"日本肝臓学会コンセンサス神戸2009--B型肝炎の診断と治療"},{"@language":"ja-Kana","@value":"ニホン カンゾウ ガッカイ コンセンサス コウベ 2009 Bガタ カンエン ノ シンダン ト チリョウ"},{"@value":"JSH Consensus Kobe 2009: Diagnosis and Treatment of Hepatitis B"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205048571520","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Case of Hepatitis B Virus/human Immunodeficiency Virus Coinfection in a Patient Who Achived Hepatitis B Surface Antigen Seroclearance After Interferon Therapy Followed by Antiretroviral Therapy without Developing Immune Reconstitution Inflammatory Syndrome"},{"@language":"ja","@value":"インターフェロン先行投与後の抗レトロウイルス療法により免疫再構築症候群の発症なくHBs 抗原の陰性化が得られた HBV/HIV 重複感染の1 例"},{"@value":"症例 インターフェロン先行投与後の抗レトロウイルス療法により免疫再構築症候群の発症なくHBs抗原の陰性化か得られたHBV/HIV重複感染の1例"},{"@language":"ja-Kana","@value":"ショウレイ インターフェロン センコウ トウヨ ゴ ノ コウレトロウイルス リョウホウ ニ ヨリ メンエキ サイコウチク ショウコウグン ノ ハッショウ ナク HBs コウゲン ノ インセイカ カ エラレタ HBV/HIV チョウフク カンセン ノ 1レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390005667263489664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Factors Associated with Hepatitis B Surface Antigen Kinetics and Responses in Pegylated Interferon Alpha-2a Monotherapy for Patients with Chronic Hepatitis B"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679771619840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two cases of acute hepatitis due to hepatitis E virus that are indigenous to Kitakyushu: a case report"},{"@language":"ja","@value":"北九州に土着したE型肝炎ウイルス株による急性肝炎の2例"},{"@value":"B型肝炎治療ガイドライン(第1.1版)"},{"@language":"ja-Kana","@value":"Bガタ カンエン チリョウ ガイドライン(ダイ1.1ハン)"},{"@language":"ja-Kana","@value":"キタキュウシュウ ニ ドチャク シタ Eガタ カンエンウイルスカブ ニ ヨル キュウセイ カンエン ノ 2レイ"},{"@value":"Guidelines for the management of hepatitis B virus infection"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1053/j.gastro.2008.05.031"},{"@type":"CROSSREF","@value":"10.1111/j.1872-034x.2010.00739.x_references_DOI_4p8eIxn0sjaMl8Y1q2EvgcQl7Ya"},{"@type":"CROSSREF","@value":"10.1016/j.jiac.2014.12.003_references_DOI_4p8eIxn0sjaMl8Y1q2EvgcQl7Ya"},{"@type":"CROSSREF","@value":"10.1089/jir.2014.0234_references_DOI_4p8eIxn0sjaMl8Y1q2EvgcQl7Ya"},{"@type":"CROSSREF","@value":"10.2957/kanzo.51.243_references_DOI_4p8eIxn0sjaMl8Y1q2EvgcQl7Ya"},{"@type":"CROSSREF","@value":"10.1111/hepr.12269_references_DOI_4p8eIxn0sjaMl8Y1q2EvgcQl7Ya"},{"@type":"CROSSREF","@value":"10.1007/s00535-016-1189-x_references_DOI_4p8eIxn0sjaMl8Y1q2EvgcQl7Ya"},{"@type":"CROSSREF","@value":"10.1053/j.gastro.2023.09.033_references_DOI_4p8eIxn0sjaMl8Y1q2EvgcQl7Ya"},{"@type":"CROSSREF","@value":"10.1002/hep.27962_references_DOI_4p8eIxn0sjaMl8Y1q2EvgcQl7Ya"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.402_references_DOI_4p8eIxn0sjaMl8Y1q2EvgcQl7Ya"},{"@type":"CROSSREF","@value":"10.11150/kansenshogakuzasshi.86.763_references_DOI_4p8eIxn0sjaMl8Y1q2EvgcQl7Ya"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.5432-20_references_DOI_4p8eIxn0sjaMl8Y1q2EvgcQl7Ya"},{"@type":"CROSSREF","@value":"10.3892/br.2017.944_references_DOI_4p8eIxn0sjaMl8Y1q2EvgcQl7Ya"}]}